Literature DB >> 20800934

Synthesis, anti-inflammatory evaluation and docking studies of some new fluorinated fused quinazolines.

C Balakumar1, P Lamba, D Pran Kishore, B Lakshmi Narayana, K Venkat Rao, K Rajwinder, A Raghuram Rao, B Shireesha, B Narsaiah.   

Abstract

A series of novel 8/10-trifluoromethyl-substituted-imidazo[1,2-c] quinazolines have been synthesized and evaluated in vivo (rat paw edema) for their anti-inflammatory activity and in silico (docking studies) to recognize the hypothetical binding motif of the title compounds with the cyclooxygenase isoenzymes (COX-1 and COX-2) employing GOLD (CCDC, 4.0.1 version) software. The compounds, 9b and 10b, were found to have good anti-inflammatory activity [around 80% of the standard: indomethacin]. The binding mode of the title compounds has been proposed based on the docking studies. Crown
Copyright © 2010. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20800934     DOI: 10.1016/j.ejmech.2010.07.063

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  7 in total

1.  Sunflower-Assisted Bio-Derived ZnO-NPs as an Efficient Nanocatalyst for the Synthesis of Novel Quinazolines with Highly Antioxidant Activities.

Authors:  Mahesh S; Boya Palajonnala Narasaiah; Himabindu B; Balaji G L; Jangampalli Adi Pradeepkiran; Harihara Padhy
Journal:  Antioxidants (Basel)       Date:  2022-03-31

Review 2.  2,3-Dihydroquinazolin-4(1H)-one as a privileged scaffold in drug design.

Authors:  Mariateresa Badolato; Francesca Aiello; Nouri Neamati
Journal:  RSC Adv       Date:  2018-06-07       Impact factor: 4.036

Review 3.  Chemical characteristics, synthetic methods, and biological potential of quinazoline and quinazolinone derivatives.

Authors:  Mohammad Asif
Journal:  Int J Med Chem       Date:  2014-11-12

4.  Molecular docking and biological evaluation of some thioxoquinazolin-4(3H)-one derivatives as anticancer, antioxidant and anticonvulsant agents.

Authors:  Danah S Al-Shamary; Monirah A Al-Alshaikh; Nabila Abdelshafy Kheder; Yahia Nasser Mabkhot; Syed Lal Badshah
Journal:  Chem Cent J       Date:  2017-05-31       Impact factor: 4.215

Review 5.  Drug Discovery of Plausible Lead Natural Compounds That Target the Insulin Signaling Pathway: Bioinformatics Approaches.

Authors:  Siba Shanak; Najlaa Bassalat; Ahmad Barghash; Sleman Kadan; Mahmoud Ardah; Hilal Zaid
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-20       Impact factor: 2.629

6.  Crystallography, Molecular Modeling, and COX-2 Inhibition Studies on Indolizine Derivatives.

Authors:  Katharigatta N Venugopala; Sandeep Chandrashekharappa; Christophe Tratrat; Pran Kishore Deb; Rahul D Nagdeve; Susanta K Nayak; Mohamed A Morsy; Pobitra Borah; Fawzi M Mahomoodally; Raghu Prasad Mailavaram; Mahesh Attimarad; Bandar E Aldhubiab; Nagaraja Sreeharsha; Anroop B Nair; Osama I Alwassil; Michelyne Haroun; Viresh Mohanlall; Pottathil Shinu; Rashmi Venugopala; Mahmoud Kandeel; Belakatte P Nandeshwarappa; Yasmine F Ibrahim
Journal:  Molecules       Date:  2021-06-10       Impact factor: 4.411

7.  Novel pyrazolo[3,4-d]pyrimidines: design, synthesis, anticancer activity, dual EGFR/ErbB2 receptor tyrosine kinases inhibitory activity, effects on cell cycle profile and caspase-3-mediated apoptosis.

Authors:  Mai Maher; Asmaa E Kassab; Ashraf F Zaher; Zeinab Mahmoud
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.